THURSDAY, June 25, 2020 — A French drugmaker Sanofi has shortened its timeline to get a coronavirus vaccine on the market.
Sanofi and partner GlaxoSmithKline previously said the earliest they’d have a vaccine available would be in the later half of next year, The New York Times reported.
But Sanofi, which is testing two types of coronavirus vaccines, said Tuesday that it may be able to get a vaccine approved by regulators as early as the first half of 2021.
However, “such fast-tracking and intense scale of vaccine production is totally unprecedented,” and the future is unknown, Padmini Pillai, an immunologist at MIT, told the Times.
Copyright © 2019 HealthDay. All rights reserved.
Subscribe to our Newsletter and get the complete health program for a health you.